We are live on ! Find out more
HOOK

HOOKIPA Pharma
HOOK

Delisted

HOOK was delisted on the 7th of August, 2025.

Back to rankings

40 hedge funds and large institutions have $20.9M invested in HOOKIPA Pharma in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 7 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 7

123% more call options, than puts

Call options by funds: $89K | Put options by funds: $40K

0.75% less ownership

Funds ownership: 4.4% → 3.65% (-0.75%)

15% less funds holding

Funds holding: 47 → 40 (-7)

18% less capital invested

Capital invested by funds: $25.5M → $20.9M (-$4.69M)

54% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 13

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
40
Holders Change
-7
Holders Change %
-14.89%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
16
Reduced
7
Closed
13
Calls
$89K
Puts
$40K
Net Calls
+$49K
Net Calls Change
-$12K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$890K
2
GCP
GSA Capital Partners
United Kingdom
+$94.9K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$86.3K
4
Renaissance Technologies
Renaissance Technologies
New York
+$66.4K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$36.2K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$796K
2
IC
Ikarian Capital
Texas
-$378K
3
BlackRock
BlackRock
New York
-$131K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$102K
5
BFM
Boothbay Fund Management
New York
-$83.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$20.9K +$7.33K +924 +36%
TSS
27
Two Sigma Securities
New York
$9.65K +$12.9K +1,631 New
IAIM
28
International Assets Investment Management
Florida
$8.29K – – –
GSC
29
Ground Swell Capital
South Carolina
$7.38K +$9.89K +1,247 New
Bank of America
30
Bank of America
North Carolina
$3.24K -$737 -93 -15%
NS
31
NBC Securities
Alabama
$3K – – –
Osaic Holdings
32
Osaic Holdings
Arizona
$2.46K +$119 +15 +4%
PA
33
Parallel Advisors
California
$207 +$278 +35 New
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$199 – – –
FDCDDQ
35
Federation des caisses Desjardins du Quebec
Quebec, Canada
$195 – – –
GRP
36
Global Retirement Partners
California
$178 +$238 +30 New
Citigroup
37
Citigroup
New York
$44 – – –
UBS Group
38
UBS Group
Switzerland
$38 -$9.79K -1,235 -100%
JP Morgan Chase
39
JP Morgan Chase
New York
$8 – – –
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$2 – – –
IC
41
Ikarian Capital
Texas
– -$378K -53,078 Closed
BFM
42
Boothbay Fund Management
New York
– -$83.8K -11,770 Closed
BCM
43
Bridgeway Capital Management
Texas
– -$62.3K -8,750 Closed
XT
44
XTX Topco
Cayman Islands
– -$43.5K -6,111 Closed
ACM
45
ADAR1 Capital Management
Texas
– -$35.6K -5,000 Closed
VF
46
Virtu Financial
New York
– -$31K -4,302 Closed
HF
47
HRT Financial
New York
– -$24K -3,487 Closed
DIM
48
DLK Investment Management
California
– -$22.8K -3,200 Closed
BPA
49
Beacon Pointe Advisors
California
– -$16.7K -2,340 Closed
AC
50
Apella Capital
Connecticut
– -$16.6K -1,978 Closed
1
2
3

HOOK Hedge Fund Activity: Q2 2024 in Review

40 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q2 2024, worth a combined $20.9M — down 18% from $25.5M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of HOOK and 6 opened new positions — a net loss of 7 holders — while 7 trimmed existing stakes and 16 added.

The largest buyer was EcoR1 Capital, adding an estimated $890K. The largest seller was Morgan Stanley, cutting an estimated $796K.

  • 40 institutional investors held HOOKIPA Pharma (HOOK) as of Q2 2024, down from 47 in Q1 2024.
  • Funds reported $20.9M of HOOKIPA Pharma stock for Q2 2024, down 18% quarter-over-quarter.
  • 6 funds opened new HOOKIPA Pharma positions in Q2 2024 and 13 closed out, a net change of -7 holders.
  • The largest HOOKIPA Pharma buyer in Q2 2024 was EcoR1 Capital, an estimated $890K added.
  • The largest HOOKIPA Pharma seller in Q2 2024 was Morgan Stanley, an estimated $796K sold.

Based on aggregated 13F filings for Q2 2024.